Continuous production the 'hottest trend in biopharma,' says LEWA
Continuous manufacturing can reduce costs and is already being pursued by CMOs looking to increase productivity by up to 30%, says fluid processing tech firm LEWA.
Archives for August 4, 2016
Kyowa Hakko Kirin completes $70m mAb manufacturing plant in Japan
Kyowa Hakko Kirin has completed construction on a ¥7.1bn mammalian cell-based manufacturing plant in Japan equipped with a 12,000L bioreactor.
Repligen up on Protein A and bioprocessing tech as US approves more mAbs
High US approval rates of monoclonal antibodies is driving demand for Protein A, and with the arrival of biosimilars this is unlikely to slow down, says Repligen.
US FDA orders Adaptimmune to halt fat cancer cell therapy trial
The US FDA has ordered Adaptimmune to halt a trial of its candidate liposarcoma therapy and asked for more information about how the treatment is made.